Cholesterol research sparks Alltracel rise

ALLTRACEL shares surged 14% yesterday after the pharmaceutical company announced a major new product breakthrough.

Cholesterol research sparks Alltracel rise

The Sallynoggin-based company said trials of its m-doc technology, which until now had been used as an anti-bleeding agent in first aid products, showed it also worked to clear blockages in arteries and helped to prevent heart disease.

Previous research by the company had signalled m-doc had additional qualities that lowered cholesterol in the bloodstream.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited